1. Anti-Ro52/TRIM21 is independently associated with pulmonary arterial hypertension and mortality in a cohort of systemic sclerosis patients. (2nd November 2021) Authors: Lee, AYS; Patterson, KA; Tan, DJ; Wilson, ME; Proudman, SM; Stevens, W; Nikpour, M; Sahhar, J; Ngian, G-S; Roddy, J; Roberts-Thomson, PJ; Walker, JG Journal: Scandinavian journal of rheumatology Issue: Volume 50:Number 6(2021) Page Start: 469 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cost-effectiveness of a primary care based physical activity intervention in 45-74 year old men and women: a randomised controlled trial. Issue 3 (September 1998) Authors: Stevens, W; Hillsdon, M; Thorogood, M; McArdle, D Journal: British journal of sports medicine Issue: Volume 32:Issue 3(1998) Page Start: 236 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease. (15th December 2021) Authors: Sammons, E; Hopewell, J C; Chen, F; Stevens, W; Wallendszus, K; Valdes-Marquez, E; Dayanandan, R; Knott, C; Murphy, K; Wincott, E; Baxter, A; Goodenough, R; Lay, M; Hill, M; Macdonnell, S; Fabbri, G; Lucci, D; Fajardo-Moser, M; Brenner, S; Hao, D Journal: European heart journal Issue: Volume 43:Number 14(2022) Page Start: 1416 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗